Zofran and Voltaren-xr drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zofran and Voltaren-xr. Common interactions include infection among males.
The phase IV clinical study analyzes what interactions people who take Zofran and Voltaren-xr have. It is created by eHealthMe based on reports of 6 people who take Zofran and Voltaren-xr from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
6 people who take Zofran and Voltaren-xr together, and have interactions are studied.
What is Zofran?
Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 84,330 Zofran users for its effectiveness, alternative drugs and more.
What is Voltaren-xr?
Voltaren-xr has active ingredients of diclofenac sodium. It is often used in back pain. eHealthMe is studying from 508 Voltaren-xr users for its effectiveness, alternative drugs and more.
Number of Zofran and Voltaren-xr reports submitted per year:

Common Zofran and Voltaren-Xr drug interactions by gender *:
female:
n/a
male:
- Infection
- Stomatitis
- Hypoaesthesia
- Osteonecrosis
- Pain
- Post herpetic neuralgia
- Tooth loss
- Interstitial lung disease
- Hypokalaemia
- Blindness
Common Zofran and Voltaren-Xr drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Interstitial lung disease
60+:
- Infection
- Stomatitis
- Hypokalaemia
- Bone erosion
- Deep vein thrombosis
- Herpes zoster
- Osteonecrosis
- Post herpetic neuralgia
* Approximation only. Some reports may have incomplete information.
Do you take Zofran and Voltaren-xr?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Zofran (84,330 reports)
- Voltaren-xr (508 reports)
Browse all drug interactions of Zofran and Voltaren-xr:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Zofran side effects:
- Fatigue (feeling of tiredness): 8,640 reports
- Nausea and vomiting: 8,106 reports
- Diarrhea: 7,770 reports
- Pain: 7,289 reports
- Stress and anxiety: 5,464 reports
Browse all side effects of Zofran:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Zofran interactions:
- Zofran and Aspirin: 10,735 reports
- Zofran and Tylenol: 9,367 reports
- Zofran and Prednisone: 8,033 reports
- Zofran and Protonix: 7,650 reports
- Zofran and Ativan: 7,514 reports
- Zofran and Vitamin d: 7,404 reports
- Zofran and Gabapentin: 7,142 reports
- Zofran and Omeprazole: 7,114 reports
- Zofran and Lasix: 6,995 reports
- Zofran and Benadryl: 6,668 reports
Browse all interactions between Zofran and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ondansetron hydrochloride and diclofenac sodium (the active ingredients of Zofran and Voltaren-xr, respectively), and Zofran and Voltaren-xr (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Zofran and Voltaren-xr.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Accolate and Stent - 24 seconds ago
- Profen and Prolia drug interaction - 26 seconds ago
- Meloxicam and Orphenadrine Citrate drug interaction - 26 seconds ago
- Prazosin Hydrochloride and Appetite - Decreased - 30 seconds ago
- Prazosin Hydrochloride and Appetite Decreased - 30 seconds ago
- Bentyl and Rhabdomyolysis - 34 seconds ago
- Coreg and Facial Spasm - 39 seconds ago
- Benztropine Mesylate and Alcohol drug interaction - 54 seconds ago
- Remicade and Modafinil drug interaction - 56 seconds ago
- Vidaza and Hyperbilirubinaemia - a minute ago